Merck
CN
Search Within
文件类型

224-168-1

应用筛选条件
关键词:'224-168-1'
显示 1-24 共 24 条结果 关于 "224-168-1" 范围 技术文档
Product Information Sheet - T0875
., 263(1), 80-84 (1990). 4. Baumgartner, U., et al., Colchicine Inhibits Taurodeoxycholate Transport in Pericentral But Not in Periportal Hepatocytes. Biochim. Biophys. Acta, 1539(3), 218-224 (2001).
Product Information Sheet - P3428
Approach, Humana Press (New Jersey: 1986), p. 168. 7. Xu, S-Q. et al., J. Biol. Chem., 273, 20078-20083, (1998). 8. Jeno, P. et al., Anal. Biochem., 224, 75-82 (1995). 9. O’Connell, K.L., and Stults
XP725 Antibody Number-Lot Number 071M4826
118 119 120 141 142 143 144 165 166 167 168 189 190 191 192 3.1 193 194 195 196 217 218 219 220 241 242 243 244 265 266 267 268 3.2 197 198 199 200 221 222 223 224 245
Datasheet - A7345
5. Thomas, S.M. et al., Cell, 54(6), 891-902 (1988). 6. Dunn, C. et al., J. Immunol. Meth., 224(1-2), 141-150 (1999). 7. Cahyadi, Sabrina, “Zinc in the Retinal Pigment Epithelium and Choriocapillaris
Fluorescent Calcium Probes Technical Bulletin
nm) (nm) M-1 cm-1 (nM) [Low Ca2+] [High Ca2+] FF6 360/510 340/505 33,000 135 FFP-18 364/502 335/490 32,000 415 FLUO 3 506/526 506/526 79,000 450 FURA 2 362/512 335/505 27,000 224 FURA-PE3
Product Information - CSAA1
(pY 881) P6864 Signal Transduction P y n/d y 223 RAF1 R5773 Signal Transduction P y n/d y 224 Raf Phospho (pS 621) R1151 Signal Transduction P y y y
An Update on Ligands for Prostanoid Receptors
al., Eur. J. Pharmacol., 459, 187-193 (2003). 52. Kiriyama, M., et al., Br. J. Pharmacol., 122, 217-224 (1997). 53. Bygdeman, M., Danielsson, K.G., Drugs, 62, 2459-2470 (2002). 54. Jones, R.L., et al.
Product Information Sheet - PP0500
Jimenez-Asensio, J., et al., J. Biol. Chem., 274, 32287-94 (1999). 34. Jeno, P., et al., Anal. Biochem., 224, 75-82 (1995). 35. Xu, S-Q et al., J. Biol. Chem., 273, 20078-20083 (1998). 36. O’Connell, K.L
User Guide Equinox SOP Software 2.1 for Windows XP
............... 168 Definitionen SOPs zeichnen sich durch folgende Merkmale aus: • Titel (maximal 12 Zeichen) • Kommentar (maximal 40 Zeichen) • Mehrere Arbeitsschritte (1 bis 20 Arbeitsschritte
XP725 Antibody List Lot 129K4831
Peroxiredoxin 3 P1247 10935 PRDX3 P NP_006784.1 y n/d n/d 391 JAB 1 J3395 10987 COPS5 P NP_006828.2 y y y 392 JAB 1 J3020 10987 COPS5 P NP_006828.2 y y y 224 Destrin/ADF D8940 11034 DSTN P NP_001011546.1 y y y 399
XP725 Antibody List Lot 129K4830
Peroxiredoxin 3 P1247 10935 PRDX3 P NP_006784.1 y n/d n/d 391 JAB 1 J3395 10987 COPS5 P NP_006828.2 y y y 392 JAB 1 J3020 10987 COPS5 P NP_006828.2 y y y 224 Destrin/ADF D8940 11034 DSTN P NP_001011546.1 y y y 399
XP725 Antibody List Lot 089K4791
Peroxiredoxin 3 P1247 10935 PRDX3 P NP_006784.1 y n/d n/d 391 JAB 1 J3395 10987 COPS5 P NP_006828.2 y y y 392 JAB 1 J3020 10987 COPS5 P NP_006828.2 y y y 224 Destrin/ADF D8940 11034 DSTN P NP_001011546.1 y y y 399
List of Antibodies
y y y 221 DEDAF D3316 P y y y 222 Desmin D1033 M n/d y y 223 Desmosomal Protein D1286 M y n/d n/d 224 Destrin/ADF D8940 P y y y 225 Dnase I D0188 P n/d n/d n/d 226 Dnase II D1689 P y
3D BIOPRINTING: Printing a Brighter Future
Biomater. 2019, 97, 46–73. (97) Ying, G.; Jiang, N.; Yu, C.; Zhang, Y. S. Bio-Des. Manuf. 2018, 1, 215– 224. (98) Zhu, M.; Wang, Y.; Ferracci, G.; Zheng, J.; Cho, N. J.; Lee, B. H. Sci. Rep. 2019, 9
3D BIOPRINTING: Printing a Brighter Future
Biomater. 2019, 97, 46–73. (97) Ying, G.; Jiang, N.; Yu, C.; Zhang, Y. S. Bio-Des. Manuf. 2018, 1, 215– 224. (98) Zhu, M.; Wang, Y.; Ferracci, G.; Zheng, J.; Cho, N. J.; Lee, B. H. Sci. Rep. 2019, 9
Pharmacopoeia Monograph Methods
Drop: 224 Bar (3248 psi) 2 3 4 5 te ns it y (m V) Test solution Formoterol 4 5 V) Blank 0 1 0 5 10
XP725 Antibody List
, 1828, 1824, 1823 DSC1,DSC3,DSC2,DSG1 NP_077741.2,NP_001933.2,NP_077740.1,NP_077739.1 M y n/d n/d 224 Destrin/ADF D8940 56431, 296197, 11034 Dstn_predicted,Dstn,DSTN NP_062745.1,XP_215862.3,NP_006861.1
XP725 Antibody List 013M4793
, 1828, 1824, 1823 DSC1,DSC3,DSC2,DSG1 NP_077741.2,NP_001933.2,NP_077740.1,NP_077739.1 M y n/d n/d 224 Destrin/ADF D8940 56431, 296197, 11034 Dstn_predicted,Dstn,DSTN NP_062745.1,XP_215862.3,NP_006861.1
Halal Certificate
3-DECANONE 97% W396605 A12275 HC-23SI3N25 224. 3-DECEN-2-ONE PREDOMINANTLY TRANS, 97% W353205 A65269 HC-23SIGW82 225. 3-ETHYL-2-HYDROXY-2-CYCLOPENTEN-1-ONE SOLUTION 50 WT. % IN PROPYLENE GLYCOL
Halal Certificate
3-DECANONE 97% W396605 A12275 HC-22SI8N46 224. 3-DECEN-2-ONE PREDOMINANTLY TRANS, 97% W353205 A65269 HC-22SI5404 225. 3-ETHYL-2-HYDROXY-2-CYCLOPENTEN-1-ONE SOLUTION 50 WT. % IN PROPYLENE GLYCOL
XP725 Worksheet for Lot Number 071M4826
B0561 162 1 4 3 2 BUB1 B0561 163 1 4 3 3 BUBR1 B9310 164 1 4 3 4 BUBR1 B9310 165 1 4 3 5 cAbl A5844 166 1 4 3 6 cAbl A5844 167 1 4 3 7 cCbl C9603 168 1 4 3
Operating Manual Spectroquant® Colorimeter Move 100
0.10 - 2.00 mg/l F RB Test 16 mm 223 Fluoride 00822 1.00822.0001 0.08 - 2.00 mg/l F RB Test 24 mm 224 Fluoride 17236 1.17236.0001* 0.08 - 2.00 mg/l F RB Test 16 mm 230 Hydrazine 09711 1.09711.0001* 10
Stem Cell and Specialty Cell Culture Product Guide
Catalogue No. TRAPeze-RT Telomerase Detection Kit 1 kit (224 reactions) S7710 Description Qty/Pk Catalogue No. CpGenome™ Universal DNA Modification Kit 1 kit (100 reactions) S7820 Telomerase Activity
Manual Spectroquant Multy - Operating manual
close with the screw cap, and mix. Measuring range: 5 – 160 mg/l Ca 16-mm cell 7 – 224 mg/l CaO 16-mm cell 13 – 400